We show that FXR, when activated by a non-steroidal agonist, induced the transcription of the liver tumor suppressor candidate NDRG2 [26] in mouse liver and three different human hepatoma cell lines. This evidence concerns the gene NDRG2 and hepatocellular carcinoma.